{"title":"轻度 COVID-19 感染康复患者的超声心动图评估：病例对照研究","authors":"Hedieh Alimi, Leila Bigdelu, Hoorak Poorzand, Fereshteh Ghaderi, Maryam Emadzadeh, Asal Yadollahi, Azadeh Izadi-Moud, Afsoon Fazlinezhad, Maedeh Rezaei Danesh","doi":"10.4103/jcecho.jcecho_3_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Coronavirus disease 2019 (COVID-19) has been revealed as a severe illness with a wide-ranging cardiac manifestation and has a worldwide burden on the health-care system.</p><p><strong>Aims: </strong>Our aim in this study is to assess the impact of mild COVID-19 infection on cardiac function in patients without previous structural heart disease.</p><p><strong>Settings and design: </strong>We evaluated 100 outpatients with a history of mild COVID-19 infection without needing hospitalization within 3 weeks to 3 months after recovery from the acute phase of the illness between August 2020 and July 2021.</p><p><strong>Subjects and methods: </strong>The patients were compared with 105 healthy participants without a history of COVID-19 as the control group. All participants underwent comprehensive transthoracic echocardiography.</p><p><strong>Statistical analysis used: </strong>Data were analyzed using IBM SPSS statistics 23. For all tests, <i>P</i> < 0.05 was defined as statistically significant.</p><p><strong>Results: </strong>COVID-19 patients had higher global longitudinal strain (<i>P</i> = 0.001), systolic pulmonary artery pressure (<i>P</i> = 0.008), RV E' (<i>P</i> = 0.049), and RV A' (<i>P</i> = 0.003), while had lower septal tissue velocities (<i>P</i> = 0.01) and left ventricular ejection fraction (EF) (LVEF) (<i>P</i> = 0.03). Abnormal EF (LVEF <55%) was noted in 19% of the COVID-19 patients and 8.6% of the control group (<i>P</i> = 0.03). Moderate or more diastolic dysfunction was noted in 10 COVID-19 patients but only in one participant in the control group (<i>P</i> = 0.005).</p><p><strong>Conclusions: </strong>Mild COVID-19 infection can result in cardiac functional and structural changes, even in patients without known previous structural heart disease. Echocardiography can be a useful modality for risk assessment and follow-up in patients with COVID-19.</p>","PeriodicalId":15191,"journal":{"name":"Journal of Cardiovascular Echography","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288305/pdf/","citationCount":"0","resultStr":"{\"title\":\"Echocardiographic Assessment of Recovered Patients with Mild COVID-19 Infection: A Case-Control Study.\",\"authors\":\"Hedieh Alimi, Leila Bigdelu, Hoorak Poorzand, Fereshteh Ghaderi, Maryam Emadzadeh, Asal Yadollahi, Azadeh Izadi-Moud, Afsoon Fazlinezhad, Maedeh Rezaei Danesh\",\"doi\":\"10.4103/jcecho.jcecho_3_24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Context: </strong>Coronavirus disease 2019 (COVID-19) has been revealed as a severe illness with a wide-ranging cardiac manifestation and has a worldwide burden on the health-care system.</p><p><strong>Aims: </strong>Our aim in this study is to assess the impact of mild COVID-19 infection on cardiac function in patients without previous structural heart disease.</p><p><strong>Settings and design: </strong>We evaluated 100 outpatients with a history of mild COVID-19 infection without needing hospitalization within 3 weeks to 3 months after recovery from the acute phase of the illness between August 2020 and July 2021.</p><p><strong>Subjects and methods: </strong>The patients were compared with 105 healthy participants without a history of COVID-19 as the control group. All participants underwent comprehensive transthoracic echocardiography.</p><p><strong>Statistical analysis used: </strong>Data were analyzed using IBM SPSS statistics 23. For all tests, <i>P</i> < 0.05 was defined as statistically significant.</p><p><strong>Results: </strong>COVID-19 patients had higher global longitudinal strain (<i>P</i> = 0.001), systolic pulmonary artery pressure (<i>P</i> = 0.008), RV E' (<i>P</i> = 0.049), and RV A' (<i>P</i> = 0.003), while had lower septal tissue velocities (<i>P</i> = 0.01) and left ventricular ejection fraction (EF) (LVEF) (<i>P</i> = 0.03). Abnormal EF (LVEF <55%) was noted in 19% of the COVID-19 patients and 8.6% of the control group (<i>P</i> = 0.03). Moderate or more diastolic dysfunction was noted in 10 COVID-19 patients but only in one participant in the control group (<i>P</i> = 0.005).</p><p><strong>Conclusions: </strong>Mild COVID-19 infection can result in cardiac functional and structural changes, even in patients without known previous structural heart disease. Echocardiography can be a useful modality for risk assessment and follow-up in patients with COVID-19.</p>\",\"PeriodicalId\":15191,\"journal\":{\"name\":\"Journal of Cardiovascular Echography\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288305/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cardiovascular Echography\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/jcecho.jcecho_3_24\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/6/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular Echography","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jcecho.jcecho_3_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/28 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Echocardiographic Assessment of Recovered Patients with Mild COVID-19 Infection: A Case-Control Study.
Context: Coronavirus disease 2019 (COVID-19) has been revealed as a severe illness with a wide-ranging cardiac manifestation and has a worldwide burden on the health-care system.
Aims: Our aim in this study is to assess the impact of mild COVID-19 infection on cardiac function in patients without previous structural heart disease.
Settings and design: We evaluated 100 outpatients with a history of mild COVID-19 infection without needing hospitalization within 3 weeks to 3 months after recovery from the acute phase of the illness between August 2020 and July 2021.
Subjects and methods: The patients were compared with 105 healthy participants without a history of COVID-19 as the control group. All participants underwent comprehensive transthoracic echocardiography.
Statistical analysis used: Data were analyzed using IBM SPSS statistics 23. For all tests, P < 0.05 was defined as statistically significant.
Results: COVID-19 patients had higher global longitudinal strain (P = 0.001), systolic pulmonary artery pressure (P = 0.008), RV E' (P = 0.049), and RV A' (P = 0.003), while had lower septal tissue velocities (P = 0.01) and left ventricular ejection fraction (EF) (LVEF) (P = 0.03). Abnormal EF (LVEF <55%) was noted in 19% of the COVID-19 patients and 8.6% of the control group (P = 0.03). Moderate or more diastolic dysfunction was noted in 10 COVID-19 patients but only in one participant in the control group (P = 0.005).
Conclusions: Mild COVID-19 infection can result in cardiac functional and structural changes, even in patients without known previous structural heart disease. Echocardiography can be a useful modality for risk assessment and follow-up in patients with COVID-19.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
